Lyell Immunopharma, Inc. (LYEL)
Chart Events
Performance Outlook
| Previous Close | 3.9100 |
| Open | 4.0200 |
| Bid | 4.0200 x 1000 |
| Ask | 4.0400 x 1100 |
| Day's Range | 3.8600 - 4.1600 |
| 52 Week Range | 3.8600 - 19.8400 |
| Volume | |
| Avg. Volume | 1,307,516 |
| Market Cap | 996.847M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.8410 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17.33 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for LYEL
Related Research
- Lyell Immunopharma, Inc.Technical Assessment: Bearish in the Intermediate-TermVolatility in West Texas Intermediate (WTI) crude oil has started to shrink a bit, with the recent range between the high $90s and $110 and with WTI currently sitting at $105/barrel. After going parabolic in March and reaching $130, crude oil pulled back to $93.50, rallied back to $116.65, and fell to an intraday low of $93 on April 11 before rallying back above $107. It is still possible that WTI is tracing out symmetrical triangle, although the past breakout attempt in early May failed.RatingFair ValueEconomic Moat5 days agoArgus Research
- GlobeNewswire
Lyell Immunopharma Reports First Quarter Financial Results and Business Highlights
Cash, cash equivalents and marketable securities of $838 million as of March 31, 2022 supports advancing a robust cell therapy pipelineResearch highlighting novel reprogramming technologies designed to overcome barriers to successful adoptive cell therapy in solid tumors presented at multiple scientific conferences SOUTH SAN FRANCISCO, Calif., May 10, 2022 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc., (Lyell) (Nasdaq: LYEL), a T-cell reprogramming company dedicated to the mastery of T cells to c
- Zacks
Reata (RETA) Q1 Earnings Top, Omaveloxolone MAA Likely in Q4
Reata (RETA) reports a narrower-than-expected loss for the first quarter of 2022 while revenues miss estimates.
- Simply Wall St.
What Type Of Shareholders Own The Most Number of Lyell Immunopharma, Inc. (NASDAQ:LYEL) Shares?
A look at the shareholders of Lyell Immunopharma, Inc. ( NASDAQ:LYEL ) can tell us which group is most powerful. Large...
